AMPD1: a novel therapeutic target for reversing insulin resistance

BACKGROUND: Insulin resistance is one of the hallmark manifestations of obesity and Type II diabetes and reversal of this pathogenic abnormality is an attractive target for new therapies for Type II diabetes. A recent report that metformin, a drug known to reverse insulin resistance, demonstrated in...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Endocr Disord
Main Authors: Cheng, Jidong, Morisaki, Hiroko, Toyama, Keiko, Sugimoto, Naomi, Shintani, Takuya, Tandelilin, Andreas, Hirase, Tetsuaki, Holmes, Edward W, Morisaki, Takayuki
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2014
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4274759/
https://ncbi.nlm.nih.gov/pubmed/25511531
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6823-14-96
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki